REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
03/11/2025
Voltar para busca
Dado oficial do USPTO
SENZAGEN
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
SENZAGEN
ST13
US500000079258436Classe
1, 5, 42, 44
Pedido
79258436
Registro
6187125
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
40
Atualização mais recente
04/11/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 42, 44
Data de depósito
17/11/2017
Data de registro
03/11/2020
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
03/11/2020
Última transação
04/11/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
SE
Examinador
KIDWELL WALKER,JACLYN NOEMI
Unidade examinadora
L20
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
SenzaGen AB
Representantes
Bradley L. Cohn Pattishall, McAuliffe, et al
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Diagnostic preparations for analysis of toxicological properties of chemical compounds and mixtures for scientific testing and screening purposesperformed in laboratoriesresearch and scientific use; assays for analysis of toxicological properties of chemical compounds and mixtures for scientific testing and screening purposesperformed in laboratoriesresearch and scientific use; diagnostic biomarkers for analysis of toxicological properties of chemical compounds and mixtures for scientific testing and screening purposesperformed in laboratoriesresearch and scientific use; diagnostic preparationsassays and biomarkers for use in in vitro testingassessment of toxicological properties of chemical compounds and mixturesgenomic analysisassessment of chemical skin sensitizersrespiratory sensitizers and potency classification of chemicalschemical compounds and mixtureschemical sensitizersagrochemicalsindustrial chemicalsnatural extractscosmetics and cosmetic ingredientspharmaceuticals and pharmaceutical candidatesmedical devices and materialsconsumer productsfor scientific testing and screening purposesperformed in laboratories for scientific testing and screening purposes; diagnostic preparationsassays and biomarkers for screening of pharmaceutical candidatessafety and potency classification of chemicalssafety and potency testing of cosmetic ingredients and assessment of sensitizers for industry and regulatory purposesfor scientific testing and screening purposesnot for medical or veterinary use
Classe 5
Diagnostic preparations for medical use; assays for medical use; diagnostic biomarkers for medical use; diagnostic preparationsassays and biomarkers for use in in vitro testingassessment of toxicological properties of chemical compounds and mixturesgenomic analysisassessment of chemical skin sensitizersrespiratory sensitizers and potency classificationall for medical testing and screening purposes; diagnostic preparationsassays and biomarkers for screening of pharmaceutical candidatessafety and potency classification of chemicalssafety and potency testing of cosmetic ingredients and assessment of sensitizers for industry and regulatory purposes in the medical and pharmaceutical industriesall for medical and pharmaceutical medical-based testing and screening purposes
Classe 42
Scientific and technological servicesresearch and design in the field of genomicsin vitro and animal free testingtesting of toxicological properties of chemical compounds and mixtures and chemical sensitizersscreening of productsmaterials and substances for sensitizersallergens and potency classification; scientific industrial analysis and research services in the field of genomicsin vitro and animal free testingtesting of toxicological properties of chemical compounds and mixtures and chemical sensitizersscreening of productsmaterials and substances for sensitizersallergens and potency classification; scientific research and development; conducting research in the field of genomics and animal-free product testing; laboratory services in the field of genomics and animal-free product testing; in vitro analysis and dermal and respiratory analysis of chemicalschemical compounds and mixtureschemical sensitizersagrochemicalsindustrial chemicalsnatural extractscosmetics and cosmetic ingredientspharmaceuticals and pharmaceutical candidatesmedical devices and materialsconsumer products for scientificmedical and pharmaceutical research purposes; assessment of toxicological properties of chemical compounds and mixturesfor medicalpharmaceutical and scientific research services and for medical research and scientific research purposes; in vitro skin and respiratory sensitization analysis of chemicalschemical compounds and mixtureschemical sensitizersagrochemicalsindustrial chemicalsnatural extractscosmetics and cosmetic ingredientspharmaceuticals and pharmaceutical candidatesmedical devices and materialsconsumer productsfor medicalpharmaceutical and scientific research services and for medical research and scientific research purposes; in vitro safety assessments of chemicalschemical compounds and mixtureschemical sensitizersagrochemicalsindustrial chemicalsnatural extractscosmetics and cosmetic ingredientspharmaceuticals and pharmaceutical candidatesmedical devices and materialsconsumer productsfor medicalpharmaceutical and scientific research services and for medical research and scientific research purposes; in vitro testing for assessment of chemical skin sensitizersrespiratory sensitizers and potency classification for scientificmedical and pharmaceutical research services and for medical research and scientific research purposes; allergy analysis and animal-free allergy analysis of consumer productschemical productscosmetic productspharmaceutical products and medical products for medical and pharmaceutical purposes; custom development of sensitization assays for prediction and classification of chemical sensitizers; safety and potency classification of chemicalsfor medicalpharmaceutical and scientific research services; safety and potency testing of cosmetic ingredients; assessment of sensitizers for industry product testing and regulatory purposes in the medical and pharmaceutical industries; safety assessments of chemicals and proteins in the medical and pharmaceutical industries; in vitro product testing assessment of allergensin the medical and pharmaceutical industries; sensitization product testing for the pharmaceuticalcosmetic and chemical industry; informationadvisory and consultancy services relating to genomicsin vitro and animal free testingtesting of toxicological properties of chemical compounds and mixtures and chemical sensitizersscreening of productsmaterials and substances for sensitizersallergens and potency classificationproduct testing assessment of toxicological properties of chemical compounds and mixtures for medical and pharmaceutical research purposes; animal-free product testing of chemical compoundsgenomic product testinganimal-free genomic product testingdermal and respiratory in vitro product testing and analysisin vitro skin and respiratory sensitization product testing and analysisin vitro product safety assessmentsproduct testing and assessment of sensitizersin vitro product testing for assessment of chemical skin sensitizersrespiratory sensitizers and potency classificationall for medical and pharmaceutical product safety purposes; screening of pharmaceutical candidatessafety and potency classification of chemicalssafety and potency testing of cosmetic ingredients and assessment of sensitizers for industry and regulatory purposes in the medical and pharmaceutical industries and for medical research and scientific research purposes; safety assessment of chemicals and proteinsin vitro assessment of allergensall for medical and pharmaceutical purposes and for medical research and scientific research purposes; sensitization product testing for the pharmaceutical and cosmetic industries; in vitro safety and toxicity testing of medical devices
Classe 44
In vitro testing for medical and pharmaceutical diagnostic purposes; allergy testing and animal-free allergy testingall for medical and pharmaceutical diagnostic purposes; informationadvisory and consultancy services relating thereto
Publicações
Histórico de despachos e eventos da marca no USPTO.
40 publicações encontradas
NREP
NEW REPRESENTATIVE AT IB RECEIVED
02/04/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
29/01/2023
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
07/03/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
13/02/2021
FIMP
FINAL DISPOSITION PROCESSED
13/02/2021
LIMN
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
03/02/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
03/02/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
03/11/2020
ATRV
ATTORNEY REVIEW COMPLETED
08/10/2020
CREV
CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
19/08/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
18/08/2020
PUBO
PUBLISHED FOR OPPOSITION
18/08/2020
GPNX
NOTIFICATION PROCESSED BY IB
14/08/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
29/07/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
29/07/2020
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
29/07/2020
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
24/07/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
16/07/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
16/07/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
16/07/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
16/07/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
16/07/2020
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
10/07/2020
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
29/01/2020
GNFR
FINAL REFUSAL E-MAILED
29/01/2020
CNFR
FINAL REFUSAL WRITTEN
29/01/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
23/12/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
23/12/2019
ALIE
ASSIGNED TO LIE
23/12/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/12/2019
RFNT
REFUSAL PROCESSED BY IB
05/07/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
08/06/2019
RFRR
REFUSAL PROCESSED BY MPU
08/06/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
21/05/2019
CNRT
NON-FINAL ACTION WRITTEN
20/05/2019
MAFR
APPLICATION FILING RECEIPT MAILED
14/05/2019
DOCK
ASSIGNED TO EXAMINER
10/05/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/05/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
09/05/2019
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace SENZAGEN ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.